DESITIN PHARMA A/S: Financial statements 2023
CVR: 19389006
Source: annual report 2023, Danish Business Authority
01/10/2022 – 30/09/2023
DESITIN PHARMA A/S (CVR 19389006) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 3,043,433 and a net result of DKK 2,606,443 compared with DKK 346,301 the year before. That is a decrease of 12.3% compared with the year before. Equity in the 2023 report amounted to DKK 8,644,840. The solvency ratio was 88.1%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 3,043,433
- Profit/Loss
- DKK 2,606,443
- Equity
- DKK 8,644,840
- Total Assets
- DKK 9,817,567
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 3M | 2.6M | 8.6M | 2 |
| 2022 | - | 3.5M | 346K | 6.4M | 2 |
| 2021 | - | 3.8M | 353K | 6.4M | 2 |
| 2020 | - | 4.2M | 430K | 6.1M | 3 |
| 2019 | - | 5.7M | 541K | 5.7M | 4 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of November 10, 2023, EMIT P/S has been appointed auditor of DESITIN PHARMA A/S.
As of November 10, 2023, J&P Invest, Kbh. ApS has stepped down as auditor of DESITIN PHARMA A/S.
DESITIN PHARMA A/S has published its annual report for 2022. Gross profit came to DKK 3,469,531, and the net result was DKK 346,301.
About DESITIN PHARMA A/S
DESITIN PHARMA A/S is a Danish company of the type Aktieselskab based in København V, founded in 1996. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Eli Lønne. The board consists of Philipp Andreas Bloching (chair), Eli Lønne and Oliver Christoph. The company is owned by Desitin Arzneimittel GmbH. The company has 1 employee (2026). In 2026, the company reported a gross profit of DKK 3,230,179 and a net result of DKK 350,332 compared with DKK 288,733 the year before. Equity in the 2026 report amounted to DKK 7,394,472.